Task: Answer the multiple choice question.
Question: Which drug exhibits a -8.356\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a. Cc1ccc(N=Nc2c(N)[nH]n3c(=O)cc(-c4ccccc4)nc23)cc1
b. Cc1ccc(CNC(=O)C2CCCN(S(C)(=O)=O)C2)cc1
c. Cc1ccnc(NC(=O)CC(NC(=O)c2ccccc2Cl)c2ccccc2)c1
Answer: c. Cc1ccnc(NC(=O)CC(NC(=O)c2ccccc2Cl)c2ccccc2)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccnc(NC(=O)CC(NC(=O)c2ccccc2Cl)c2ccccc2)c1
Cc1ccnc(NC(=O)CC(NC(=O)c2ccccc2Cl)c2ccccc2)c1
2-chloro-N-[3-[(4-methylpyridin-2-yl)amino]-3-oxo-1-phenylpropyl]benzamide